Remarkably, PDE10A inhibitors can reduce behavioral, neurodegenerative, and electrophysiological deficits in HD animal models [111,115,120], possibly via increasing pCREB in striatum, cortex and hippocampus in both HD patients and animal models [121]. Here, PDE10A is linked to Huntington disease.